📰 Reference Networks News
Page 2 - Reference Networks News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reference Networks. Real-time updates on events, politics, business and more.
December 12, 2020
No Deal Brexit could endanger lives of four million Brits with rare diseases Updated: 12 Dec 2020, 3:35 Invalid Date, A NO-DEAL Brexit would have a detrimental impact on the care received by the four million Brits who suffer from a rare disease, a group of leading clinicians have said. The warning comes after Prime Minister Boris Johnson said on Friday it was "very, very likely" the UK would be leaving the UK without a deal in place. 2 The treatment received by four million Brits with a rare...
December 12, 2020
Experts and patient support groups signed a letter in prestigious journal Lancet Claims dropping out of Europe without a deal on January 1 will endanger lives It could see Briain lose access to networks established to research rare diseases These so-called ERNs allow for crucial research to take place internationally and a no deal Brexit will leave the 4 million Brits with rare diseases at a disadvantage
December 12, 2020
No deal Brexit could endanger the lives of four MILLION Britons Joe Pinkstone For Mailonline © Provided by Daily Mail MailOnline logo If the UK slams out of Europe without a deal it could leave the four million Britons with rare diseases with subpar medical treatment, experts have warned. A total of 53 leading clinicians and 20 patient support groups have signed a letter warning of the impact No Deal will have. They say that without a deal the UK will lose access to the ...
December 12, 2020
E-Mail Experts have warned that a no deal Brexit will result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that were established to improve the care of patients bearing the lifelong burden of a rare disease, which require highly specialised diagnosis and treatment. One in 17 UK citizens lives with a rare disease, which are defined as conditions that affect fewer than one in 2,000 people in the general population. A group of experts has written to The Lancet highli...